Friday December 15th 2017

Psychometric Properties of the MSIS-29 and Factors Predicting Score Changes in Clinical Trials: An Analysis of Data from the SELECT Study (P3.131)

CONCLUSIONS: The MSIS-29 demonstrated good psychometric properties among patients in the SELECT trial and may be appropriate to consider as an efficacy endpoint in clinical trials.Study Supported by: Biogen Idec, AbbVie Biotherapeutics.Disclosure: Dr. Phillips has received personal compensation for activities with Biogen Idec as an employee. Dr. Phillips holds stock and/or stock options in Biogen Idec which sponsored research in which Dr. Phillips was involved as an investigator. Dr. Castelli-Haley has received personal compensation for activities with AbbVie as an employee. Dr. Castelli-Haley holds stock and/or stock options in AbbVie. Dr. Guo has received personal compensation for activities with Evidera as an employee. Dr. Proskorovsky has received personal compensation for activities w…

Visit link – 

Psychometric Properties of the MSIS-29 and Factors Predicting Score Changes in Clinical Trials: An Analysis of Data from the SELECT Study (P3.131)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]